Gastric mucosal molecular targets

Gastric mucosal molecular targets refer to a collective group of proteins, receptors, and enzymes located within the stomach lining that are essential for maintaining the balance between aggressive factors and protective mechanisms. The primary therapeutic target in this group is the Hydrogen potassium ATPase (H+/K+ ATPase), or proton pump, which is the final common pathway for acid secretion in parietal cells (StatPearls, 2023). Other significant targets include the Histamine H2 receptor, Muscarinic M3 receptor, and Cholecystokinin B receptor, which stimulate acid production, as well as Prostaglandin E receptors (specifically EP3) and Cyclooxygenase (COX) enzymes that facilitate mucosal defense (PubMed, 2001). In the context of oncology, specific proteins like Claudin 18.2 have emerged as critical molecular targets for monoclonal antibody therapies in gastric cancer (NIH, 2023). Pharmacological intervention at these targets is fundamental to treating conditions such as peptic ulcers, gastroesophageal reflux disease (GERD), and gastric malignancies. However, long-term modulation of these targets can lead to physiological changes such as hypergastrinemia, altered gastric pH, and potential nutrient malabsorption (PubMed, 2017).

Other names

Gastric mucosal targetsGastric acid secretion targetsGastric mucosal defense targetsGastric mucosal barrier targets

Inhibition of the H+/K+ ATPase proton pump, antagonism of H2 histamine receptors, agonism of prostaglandin EP3 receptors, induction of heat shock proteins, and targeting of Claudin 18.2 tight junction proteins.